veliflapon (DG-031)

SUSPENDED · PHASE3 · Acute Coronary Syndrome

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.